Biophysical basis of hypoxic radioprotection by deoxygenated dextran-hemoglobin.
Perfusion with deoxygenated dextran-hemoglobin provides an effective method for inducing hypoxic radioprotection of normal tissues during radiation treatment of tumors. In this study, the dependence of P50, the half-saturation pressure of oxygen binding to dextran-hemoglobin, was analyzed as a function of solution temperature and pH. The variation of attainable radioprotection with P50, and with the amount of collateral blood entering into the perfused region, was calculated. Upon perfusion of canine gracilis muscle with deoxygenated dextran-hemoglobin, a rapid onset of extensive venous hypoxia was observed.
D000818:Animals; D003911:Dextrans / Q000494:pharmacology*; D004285:Dogs; D006454:Hemoglobins / Q000494:pharmacology*; D009132:Muscles / Q000187:drug effects / Q000378:metabolism; D010100:Oxygen / Q000097:blood; D011837:Radiation-Protective Agents / Q000494:pharmacology*
D003911:Dextrans; D006454:Hemoglobins; D011837:Radiation-Protective Agents; C040953:dextran-hemoglobin complex (deoxygenated); D010100:Oxygen